Navigation Links
Mutation in gene IDH a possible target for AML treatment
Date:7/13/2012

Many patients with acute myeloid leukemia (AML) share a mutation in a gene called IDH. A University of Colorado Cancer Center study published this week in the journal Leukemia & Lymphoma shows that this IDH mutation may be the first domino in a chain that leads to a more aggressive form of the disease.

"In fact, it's not IDH itself that causes the problem," says Dan Pollyea, MD, MS, investigator at the CU Cancer Center and assistant professor of hematologic oncology at the University of Colorado School of Medicine. Rather, the mutation in IDH leads to exponentially higher blood levels of a protein called 2-hydroxyglutarate. This protein "mucks up," as Pollyea says, other genes that in turn promote cancer or fail to inhibit its growth.

The recent study shows that AML patients in remission who retain high levels of 2-hydroxyglutarate due universally to IDH mutation are much more likely to relapse than patients without similarly elevated levels.

The chain of causation includes another couple links.

"2-hydroxyglutarate reduces genes' ability to regulate themselves," says Pollyea. Over time genes accumulate gunk in the form of methylation these methyl groups attach to silence parts of gene promoters, helping to decide which genes are and are not turned into proteins. Too much methylation is associated with many cancers, including AML. And 2-hydroxyglutarate turns off one of the body's methylation-regulating genes.

So an IDH mutation leads to high 2-hydroxyglutarate, leads to bad gene regulation, leads to hypermethylation, leads to AML.

Pollyea hopes to stop the first domino from falling by targeting IDH mutations. "Imagine screening for patients prospectively and then if they have the mutation, we could use something like an IDH inhibitor," Pollyea says. Turn off this mutation and doctors may be able to turn of the disease, or at least its most aggressive characteristics.

But the genetic te
'/>"/>

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver
Source:Eurekalert

Page: 1 2

Related medicine news :

1. KRAS gene mutation and amplification status affects sensitivity to antifolate therapy
2. Researchers Find Gene Mutations That May Be a Key to Autism
3. Mayo Clinic breast cancer study finds new type of mutation
4. Scientists make breakthrough in bile duct cancer with discovery of new gene mutations
5. Cancer may require simpler genetic mutations than previously thought
6. Mutations impair childhood growth and development by disrupting organization of chromosome pairs
7. Study sheds new light on role of genetic mutations in colon cancer development
8. Mutations in JAK3 gene identified in subtype of lymphoma provide potential drug target
9. Study finds new gene mutations that lead to enlarged brain size, cancer, autism, epilepsy
10. Gene Mutation Linked to Facial, Skull Abnormalities
11. Possible new cancer treatment identified
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... MD (PRWEB) May 06, 2015 The Canton ... Baltimore Ravens for the 6th annual charity softball game. ... at M & T Bank Stadium. Past years guests include ... others. Tickets are still on sale if you ... advocating for local non-profit organizations, such as SOAR Baltimore ...
(Date:5/6/2015)... Jacksonville, Fla. (PRWEB) May 06, 2015 ... Orthopaedic Institute are the first in north Florida ... This technology is the latest innovation in total ... a highly advanced, surgeon-controlled robotic arm that enables ... Baptist Medical Center Jacksonville has offered MAKOplasty® partial ...
(Date:5/6/2015)... 2015 TMG Health, the leading national ... Advantage, Medicare Part D and Managed Medicaid markets, was ... Team category at the BCI North America Awards, a ... the outstanding contribution of business continuity professionals and organizations ... including the USA and Canada. The North America Awards ...
(Date:5/6/2015)... “ SideChef ” was featured on NewsWatch as ... latest and coolest applications on the market for iOS, Android, and ... the app review and shared with viewers how this application walks ... to be a good navigator people had to know how to ... is a master navigator. Well what if people could “GPS” their ...
(Date:5/6/2015)... Angeles (PRWEB) May 06, 2015 ... the #1 ranked international water, sanitation and hygiene nonprofit ... for communities across the world and it brings our ... Carnett, CEO of Marketing Maven. “The ongoing relationship between ... opportunities available for people to learn about and support ...
Breaking Medicine News(10 mins):Health News:The Canton Group Sponsors Ravens Charity Softball Event 2Health News:The Canton Group Sponsors Ravens Charity Softball Event 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 4Health News:TMG Health Recognized by the Business Continuity Institute 2Health News:TMG Health Recognized by the Business Continuity Institute 3Health News:An Application to Guide Users through Recipes Was Featured on NewsWatch Television 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 3
... lifestyle habits relate to the risk of certain cancers (e.g., ... authors estimate the proportion of cancer in the population associated ... find that smoking has, by far, the largest effect on ... the UK attributable to tobacco use. A poor diet ...
... hold churches and pharmaceutical companies to different moral standards ... the Journal of Consumer Research . ... that he is in the business of maximizing shareholder ... his company,s offeringsand those prices should be very high ...
... Professor of Surgery at Thomas Jefferson University and ... Cancers Center , and Mon-Li Chu, Ph.D., Professor ... Cutaneous Biology , were awarded $200,000 from the University ... for their breakthrough work on a diagnostic test ...
... - telling these smells apart is no problem for the ... has been uncovered by an interdisciplinary team of researchers at ... on the dynamics of the three-dimensional structure of the binding ... found a characteristic pattern of hydrogen bonds between odorant and ...
... DETROIT Hitching a ride into the retina on ... age-related macular degeneration and retinitis pigmentosa. A collaborative research ... Clinic and Johns Hopkins Medicine shows that steroids attached ... neuroinflammation, leaving the rest of the eye unaffected and ...
... Adding a drug that activates genes to frontline combination therapy ... rate after initial treatment, researchers at The University of Texas ... of the American Society of Hematology. Results of the ... for a national Phase III clinical trial of the new ...
Cached Medicine News:Health News:Commercial or communal: Why is outsourcing taboo for churches and pharmaceutical companies? 2Health News:Thomas Jefferson University receives Science Center's QED Award for pancreatic cancer research 2Health News:Thomas Jefferson University receives Science Center's QED Award for pancreatic cancer research 3Health News:A good nose: RUB-Researchers decipher interaction of fragrances and olfactory receptors 2Health News:Nanoparticles help researchers deliver steroids to retina 2Health News:AML patients have high response rate with vorinostat added to treatment 2
(Date:5/6/2015)... Company, Inc. (NYSE: LCI ) today reported financial ... 31, 2015.  For the fiscal 2015 ... from $80.0 million in last year,s third quarter.  Gross ... net sales, from $56.1 million, or 70% of net ... million from $10.6 million for the fiscal 2014 third ...
(Date:5/6/2015)... 2015 CVS Health (NYSE: CVS ) officially announced ... locations that sustained heavy fire damage during protests last week.  ... Baltimore over the past week or so, our hearts ... CVS Health President and CEO Larry Merlo . "Our purpose ... health. There is no better way that we can fulfill that ...
(Date:5/6/2015)... Del. , May 6, 2015  Rigrodsky & Long, P.A.: ... Aerie Pharmaceuticals, Inc. (NASDAQ GM: AERI )? , Did ... 2015, inclusive? , Did you lose money in your investment ... your rights? Rigrodsky & Long, P.A. ... MacFall , announces that a complaint has been filed in the ...
Breaking Medicine Technology:Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 2Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 3Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 4Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 5Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 6Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 7Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 8CVS Health Announces it Will Rebuild Baltimore CVS/pharmacy Locations 2SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 2SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 3
... Pharmaceuticals Inc. announced a plan to provide VX-770, a CF medicine ... critical medical need and may benefit from treatment prior to potential ... (FDA). Pending FDA review and approval, Vertex expects ... as early as July. "We are delighted that ...
... from new post hoc analyses assessing the effects of ... and utilizing novel surrogate markers suggested improved daytime functioning ... and depressive symptoms in patients with moderate to severe ... Congress of Parkinson,s disease and Movement disorders in Toronto, ...
Cached Medicine Technology:Vertex Plans to Provide Access to Potential CF Therapy VX-770 for Patients with Critical Medical Need 2New Post Hoc Analyses Examined the Effects of Neupro® (Rotigotine Transdermal System) on Daytime Functioning, Daytime Symptoms, Pain and Mood in Restless Legs Syndrome 2New Post Hoc Analyses Examined the Effects of Neupro® (Rotigotine Transdermal System) on Daytime Functioning, Daytime Symptoms, Pain and Mood in Restless Legs Syndrome 3New Post Hoc Analyses Examined the Effects of Neupro® (Rotigotine Transdermal System) on Daytime Functioning, Daytime Symptoms, Pain and Mood in Restless Legs Syndrome 4New Post Hoc Analyses Examined the Effects of Neupro® (Rotigotine Transdermal System) on Daytime Functioning, Daytime Symptoms, Pain and Mood in Restless Legs Syndrome 5New Post Hoc Analyses Examined the Effects of Neupro® (Rotigotine Transdermal System) on Daytime Functioning, Daytime Symptoms, Pain and Mood in Restless Legs Syndrome 6New Post Hoc Analyses Examined the Effects of Neupro® (Rotigotine Transdermal System) on Daytime Functioning, Daytime Symptoms, Pain and Mood in Restless Legs Syndrome 7
... Size: 3.0 x 7.5 x ... Scleral Sponge II line designed by ... material is a closed cell sponge ... are soft with rounded edges to ...
... x 80 mm. Storz offers the ... by Harvey A. Lincoff, M.D. ... sponge which is non-toxic and non-antigenic. ... to minimize scleral intrusion. These implants ...
Thin silicone pad implant. Indications: For closing scleral ruptures. Overall length: 7.8 mm....
... mm. Half oval. The original Scleral Sponge II ... been modified by Dr. Joseph Olk with this ... cell sponge which is non-toxic and non-antigenic. Implants ... intrusion. These implants are packaged sterile and sold ...
Medicine Products: